Effect of Tegoprazan on Pharmacodynamics of Clopidogrel in Healthy Subjects

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

December 5, 2023

Primary Completion Date

November 30, 2024

Study Completion Date

November 30, 2024

Conditions
Healthy
Interventions
DRUG

Clopidogrel 75 mg

Clopidogrel 75 mg tablet

DRUG

Tegoprazan 25 mg

Tegoprazan 25 mg tablet

DRUG

Esomeprazole 20mg

Esomeprazole 20 mg tablet

Trial Locations (1)

Unknown

Seoul National University Hospital, Clinical Trial Center, Seoul

Sponsors
All Listed Sponsors
lead

HK inno.N Corporation

INDUSTRY